Hinge Health (NYSE: HNGE) saw its shares climb about 3% in after-hours trading on Tuesday after the company raised revenue and profitability guidance for both the second quarter and the full year 2026.
The digital musculoskeletal health provider updated its full-year revenue outlook to a band of $818 million to $824 million. That revised range is $20 million higher at the midpoint than the company’s prior guidance and implies 40% year-over-year growth at the midpoint.
For the second quarter of 2026, Hinge Health now anticipates revenue between $200 million and $202 million, which corresponds to 45% year-over-year growth at the midpoint. Alongside the top-line increase, the company raised its non-GAAP income from operations guidance for the quarter to $50 million-$52 million, reflecting a non-GAAP operating margin of 25% at the midpoint.
On a full-year basis, Hinge Health now expects non-GAAP income from operations to fall between $217 million and $227 million, which equates to a non-GAAP operating margin of 27% at the midpoint.
Commenting on the update, James Budge, Chief Financial Officer of Hinge Health, said:
"The value we are delivering to our members, clients and partners is driving higher member conversion and performance across our client base."
The guidance revision arrived in advance of Hinge Health’s inaugural Investor Day, scheduled for June 10 at Movement, the company’s annual conference. Company leaders are set to present strategy and future opportunities at the event, which will be webcast on Hinge Health’s investor relations website starting at 1:00 pm CT.
Key numbers at a glance:
- Full year 2026 revenue guidance: $818 million - $824 million (40% YoY growth at midpoint)
- Q2 2026 revenue guidance: $200 million - $202 million (45% YoY growth at midpoint)
- Q2 2026 non-GAAP income from operations: $50 million - $52 million (25% non-GAAP operating margin at midpoint)
- Full year 2026 non-GAAP income from operations: $217 million - $227 million (27% non-GAAP operating margin at midpoint)